Replies to post #329020 on NorthWest Biotherapeutics Inc (NWBO)

[Harry1969]

Could one of the accelerated vesting conditions be responsible for a change in the accounting of option awards? Just spitballing.

[anders2211]

"Northwest Biotherapeutics, Inc. (the “Company”) was unable to file its Quarterly Report on Form 10-Q timely due to certain pending accounting and valuation matters such as those in connection with the acquisition of Flaskworks during the quarter, and due to subsequent events (after September 30) affecting the accounting for option awards during the quarter. The Company currently expects to file its report within the extension period."

mmm
interesting. what subsequent events would have affected the accounting for option awards after sept 30?

and why is the valuation of the mentioned assets so important now?
Flaskworks could be incorporated in the balance sheet for the acquired price? an why an options award (re)valuation now....?

[JTORENCE]

rogers5729 would you know how long the extension period ?